Volume 10 (2024) – 17 articles | Journal of Cancer Metastasis and Treatment

Journal of Cancer Metastasis and Treatment

ISSN 2454-2857 (Online) 2394-4722 (Print)

editorialoffice@jcmtjournal.com

Navigation

Sitemap

LinkedIn
Facebook
Twitter
Google Scholar

Navigation

Sitemap

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

partners@oaepublish.com Company Contact Us

Discover Content

Journals A-Z Language Editing Layout & Production Graphical Abstracts Video Abstracts Expert Lecture Conference Organizer Strategic Collaborators

Follow OAE

Twitter

Facebook

YouTube

BiLiBiLi

WeChat

Privacy Cookies Terms of Service

Volume

Volume 10 (2024) – 17 articles

Editorial

Editorial on “Chinese expert consensus on the clinical practice of non-small cell lung cancer fusion gene detection based on RNA-based NGS” (2023 edition)

Review

Promising future: a review of clinical applications of biopolymers in renal cell carcinoma

Photodynamic effect of indocyanine green and its application to hepatocellular carcinoma treatment

The role of melatonin as an adjuvant therapeutic strategy in the modulation of carcinogenesis. A narrative review

Research advances in immunotherapy combined with DNA damage response inhibitors for liver cancer therapy

Neutrophils in the tumor microenvironment: role in tumor progression and potential targeted therapeutic strategy

Research progress of intestinal microbiota in targeted therapy and immunotherapy of colorectal cancer

Consideration of liquid biomarkers for surveillance of HPV-related oropharyngeal cancer in veteran populations

Regulation and function of the RSK family in colorectal cancer

Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections

Mechanical force-mediated interactions between cancer cells and fibroblasts and their role in the progression of hepatocellular carcinoma

Fast-tracking drug development with biomarkers and companion diagnostics

Original Article

ImmuneScore as a novel RNA-based prognostic signature superior to PD-L1 in advanced non-squamous NSCLC patients receiving chemotherapy combined with immune checkpoint inhibitor therapy

Cancer-associated fibroblasts (CAFs) based model reveals potential for predicting bladder cancer patients’ prognoses and immunotherapy responses

Prognostic value of clonal evolution identified by sequential FISH in untreated chronic lymphocytic leukaemia

Commentary

Integration of community pharmacies in an Italian colorectal cancer screening program: insights from the Local Health Authority of Bologna

Interview

Feature interview with Dr. William C. CHO - “Clarivate 2023 Highly Cited Researcher”

Actions for 0 selected articles

Portico

Portico